DELFI Diagnostics to Participate in J.P. Morgan Healthcare Conference
BALTIMORE and PALO ALTO, Calif., Jan. 8, 2025 /PRNewswire/ -- DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, today announced the company will participate in the upcoming 43 rd Annual J.P. Morgan Healthcare Conference in San Francisco.